Compliance with RSV prophylaxis: Global physicians’ perspectives

Respiratory syncytial virus (RSV) is a significant cause of morbidity in high-risk infants. Palivizumab is proven to prevent serious RSV disease, but compliance with prophylaxis (monthly doses during the RSV season) is essential to ensure protection. We invited 453 pediatricians to participate in a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Anderson, Kari S, Mullally, Victoria M, Fredrick, Linda M, Campbell, Andrew L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2009
Aiheet:
Short Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2778415/
https://ncbi.nlm.nih.gov/pubmed/19936162
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia